Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Plc Share News (WISE)

Share Price Information for Wise Plc (WISE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 812.50
Bid: 813.00
Ask: 815.50
Change: -3.00 (-0.37%)
Spread: 2.50 (0.308%)
Open: 816.00
High: 824.00
Low: 812.00
Prev. Close: 815.50
WISE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: AstraZeneca breast cancer drugs recommended

Mon, 27th Jun 2022 07:58

(Alliance News) - Stock prices in London are seen opening higher on Monday following a strong close in the US on Friday and a rally across Asian markets, amid gatherings of world leaders and central bankers at separate meetings in Europe this week.

In early company news, Anglo-Swedish drugmaker AstraZeneca said its breast cancer treatments have been recommended for approval in the EU. Personal care products company PZ Cussons said trading is in line with expectations. Money transfers provider Wise said the UK regulator is investigating its chief executive after a tax breach.

IG futures indicate the FTSE 100 index will open 42.39 points higher at 7,251.20. The index closed up 188.36 points, or 2.7%, at 7,208.81 Friday.

AstraZeneca said its Lynparza treatment has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use for early breast cancer treatment, after positive phase-three results.

Lynparza also demonstrated a statistically significant and clinically meaningful improvement in overall survival, reducing the risk of death by 32% versus placebo, the drugmaker said.

Separately, AstraZeneca said its Enhertu drug also has been recommended for approval in the European Union for patients with breast cancer.

The CHMP based its positive opinion on results from the Destiny-Breast03 phase three trial, which were published in The New England Journal of Medicine.

The trial results showed that Enhertu reduced the risk of disease progression or death by 72% compared with the trastuzumab emtansine drug.

Lynparza was co-developed by AstraZeneca with Merck & Co, while Enhertu was jointly developed with Daiichi Sankyo.

PZ Cussons said trading for the fourth quarter to May 31 has continued to be in line with expectations despite a challenging trading environment.

The maker of products such as Carex, St Tropez and Imperial Leather expects revenue for the financial year of GBP590 million, with full-year like-for-like revenue growth of 3% and fourth-quarter LFL growth of 7%. PZ Cussons recorded revenue of GBP603.3 million in financial 2021.

PZ Cussons said growth continues to be driven primarily by improvements in price mix, with limited impact on volumes. Its expectations for annual adjusted pretax profit are unchanged.

Chief Executive Officer Jonathan Myers said: "The trading environment continues to be challenging, with high input cost inflation and pressures on household budgets. We have plans in place to mitigate the impact of this, as we continue to deliver great value for consumers, whilst also investing behind more premium innovations.

"The recent introduction of our new portfolio brand, Cussons Creations, for the value-conscious consumer, alongside the re-launches of Sanctuary Spa and Imperial Leather, are good examples of such initiatives. They have been well received by customers and have allowed us to secure significant distribution gains."

Wise said the UK Financial Conduct Authority has opened an investigation into CEO Kristo Kaarmann.

Wise said that UK tax collector HM Revenue & Customs in September of last year updated its published list of individuals and businesses receiving penalties for a deliberate default regarding their tax affairs. Kaarmann was included on the list and will remain so for 12 months from its publication.

Following Kaarman's inclusion on the list, the board of Wise had conducted an investigation with the help of external legal counsel and share the findings of this with the FCA.

Wise said Kaarmann intends to cooperate fully with the FCA in its investigation.

Chair David Wells said: "The board takes Kristo's tax default and the FCA's investigation very seriously. After reviewing the matter late last year the board required that Kristo take remedial actions, including appointing professional tax advisors to ensure his personal tax matters are appropriately managed. The board has also shared details of its own findings, assessment and actions with the FCA and will cooperate fully with the FCA as and when they require, while continuing to support Kristo in his role as CEO."

Wall Street ended sharply higher on Friday, with the Dow Jones Industrial Average up 2.7%, S&P 500 up 3.1% and Nasdaq Composite up 3.3%.

In Asia on Monday, the Japanese Nikkei 225 index closed up 1.4%. In China, the Shanghai Composite was up 1.8%, while the Hang Seng index in Hong Kong was up 2.0%. The S&P/ASX 200 in Sydney ended up 1.9%.

World powers on Sunday agreed to ban gold exports from Russia, kicking off a G7 meeting aimed at taking new steps to deplete Moscow's war chest and bolster Ukraine's defences.

US President Joe Biden and his counterparts from the world's most industrialised nations are gathering at Elmau Castle in the German Alps before they continue on to Madrid for talks with NATO partners.

The leaders are seeking to close ranks for Ukraine against Russia's invasion while grappling with the intensifying global fallout of the war.

Ukraine President Volodymyr Zelensky will urge world powers to step up their support for Ukraine when he addresses the G7 summit on Monday

"The G-7 meeting probably has potentially a much greater bearing on Europe right now, than other areas, thanks to the Ukraine/Russia war. European markets piled into the buy-side with the US on Friday after a very mixed week, and with the G-7 springing no surprises thus far, we can expect a positive opening from European markets," said Oanda Markets analyst Jeffery Halley.

Meanwhile, central bank chiefs and economists gather Monday evening at their annual forum in southern Portugal to discuss the best approach to the inflationary challenges exacerbated by Russia's invasion of Ukraine.

Some 200 delegates will attend the ECB Forum on Central Banking at a luxury hotel in Sintra, west of Lisbon, after two years of Covid-imposed virtual gatherings. When ECB President Christine Lagarde last attended this event, it was in her previous role as director general of the International Monetary Fund back in 2014.

Also attending will be Jerome Powell, head of the US Federal Reserve, and Andrew Bailey, governor of the Bank of England. They will be joined by Agustin Carstens, general manager of the Bank for International Settlements, and all four are set to discuss the issues at a seminar on Wednesday, the last day of the forum.

In its annual report released on Sunday, the BIS warned that central banks must not let inflation become entrenched, with the threat of stagflation looming over the global economy.

The pound was quoted at USD1.2270 early Monday, down from USD1.2282 at the London equities close Friday.

The euro was priced at USD1.0565, up from USD1.0549. Against the yen, the dollar was quoted at JPY134.09 in London, lower against JPY135.10.

Brent oil was trading at USD112.88 a barrel Monday morning, down from USD113.44 late Friday. Gold stood at USD1,836.24 an ounce, higher against USD1,830.41.

Monday's economic calendar has US durable goods orders data at 1330 BST. The week picks up pace with a US consumer confidence reading on Wednesday, eurozone unemployment data on Thursday, before inflation readings from the single-currency bloc on Friday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
12 Oct 2022 09:52

LONDON BROKER RATINGS: Redburn likes Flutter; RBC cuts Smiths

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
11 Oct 2022 15:39

UK earnings, trading statements calendar - next 7 days

Wednesday 12 October 
Asos PLCFull Year Results
Angling Direct PLCHalf Year Results
Hostelworld Group PLCTrading Statement
Kin & Carta PLCFull Year Results
PageGroup PLCTrading Statement
Tharisa PLCTrading Statement
QinetiQ Group PLCTrading Statement
Thursday 13 October 
easyJet PLCTrading Statement
Entain PLCTrading Statement
Hays PLCTrading Statement
Sabre Insurance Group PLCTrading Statement
Norcros PLCTrading Statement
Friday 14 October 
Chrysalis Investments LtdTrading Statement
Jupiter Fund Management PLCTrading Statement
Mondi PLCTrading Statement
Monday 17 October 
Alphawave IP Group PLCTrading Statement
Audioboom Group PLCTrading Statement
City Of London Investment Trust PLCQ1 Results
EnSilica PLCFull Year Results
Rio Tinto PLCQ3 Results
Seraphim Space Investment Trust PLCFull Year Results
Tuesday 18 October 
Arbuthnot Banking Group PLCTrading Statement
Bellway PLCFull Year Results
BP Marsh & Partners PLCHalf Year Results
essensys PLCFull Year Results
FD Technologies PLCHalf Year Results
Integrafin Holdings PLCTrading Statement
Quilter PLCTrading Statement
Revolution Bars Group PLCFull Year Results
Sosandar PLCTrading Statement
Wise PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Oct 2022 10:00

LONDON BROKER RATINGS: Exane BNP starts 888 Holdings with 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
29 Sep 2022 17:00

Wise sees continued growth momentum, raises interim income guidance

(Alliance News) - Wise PLC on Thursday said it expects growth in interest income in the first half of its 2023 financial year and maintained its medium-term guidance for its adjusted earnings before interest, tax, depreciation and amortisation margin.

Read more
16 Sep 2022 15:55

UK shareholder meetings calendar - next 7 days

Monday 19 September 
Carr's Group PLCGM re Agricultural Supplies division sale
Tuesday 20 September 
AdEPT Technology Group PLCAGM
Appreciate Group PLCAGM
Cake Box Holdings PLCAGM
DP Eurasia NVEGM appointment of independent non-executive director
DSW Capital PLCAGM
FIH Group PLCAGM
Global Ports Holding PLCAGM
Gore Street Energy Storage Fund PLCAGM
Ilika PLCAGM
Manolete Partners PLCAGM
Moonpig Group PLCAGM
ProCook Group PLCAGM
Quiz PLCAGM
Shearwater Group PLCAGM
SulNOx Group PLCAGM
Utilico Emerging Markets Trust PLCAGM
Zoo Digital Group PLCAGM
Wednesday 21 September 
Games Workshop Group PLCAGM
Hipgnosis Songs Fund LtdAGM
IG Group Holdings PLCAGM
India Capital Growth Fund LtdAGM
Merit Group PLCAGM
Schroder Real Estate Investment Trust LtdAGM
SDI Group PLCAGM
Seraphine Group PLCAGM
Tintra PLCAGM
Thursday 22 September 
Begbies Traynor Group PLCAGM
Ecofin Global Utilities & Infrastructure Trust PLCGM pre-emption rights
IG Design Group PLCAGM
Liontrust Asset Management PLCAGM
Oberon Investments Group PLCAGM
Odyssean Investment Trust PLCAGM
Rockwood Strategic PLCGM trading to the premium segment
Trakm8 Holdings PLCAGM
Worsley Investors LtdAGM
Friday 23 September 
Accsys Technologies PLCAGM
Biffa PLCAGM
Bradda Head Lithium LtdAGM
Fusion Antibodies PLCAGM
In The Style Group PLCAGM
Safestay PLCAGM
Wise PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
31 Aug 2022 12:17

Wise subsidiary Wise Nuqud fined USD360,000 in Abu Dhabi

(Alliance News) - Abu Dhabi Global Market's Financial Services Regulatory Authority on Tuesday said it fined a subsidiary of Wise PLC, Wise Nuqud Ltd, for failing to comply with anti-money laundering requirements.

Read more
8 Aug 2022 09:37

LONDON BROKER RATINGS: JPMorgan raises L&G but cuts M&G and Phoenix

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Jul 2022 14:40

IN BRIEF: Wise chief technology officer sells GBP106,000 in shares

Wise PLC - London-based company offering international money transfers, rebranded from TransferWise - Chief Technology Officer Harsh Sinha sells 25,000 shares at GBP4.24 each, worth around GBP106,083, in London on Thursday last week.

Read more
22 Jul 2022 09:33

LONDON BROKER RATINGS: Morgan Stanley cuts S4 Capital and raises Wise

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
21 Jul 2022 09:52

LONDON BROKER RATINGS: Citi likes Haleon, resumes GSK at 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
19 Jul 2022 17:06

LONDON MARKET CLOSE: Stocks rise on Nord Stream 1 restart report

(Alliance News) - Stocks in London ended higher on Tuesday amid hopes of a restart of natural gas supplies after months of brinkmanship by Russia over the flow to Germany and the rest of Europe.

Read more
19 Jul 2022 12:16

LONDON MARKET MIDDAY: Europe shakes off slow start; Netflix ahead

(Alliance News) - European equities found their groove by midday on Tuesday, after a stumbling open prompted by a report that Apple is slowing hiring and spending plans.

Read more
19 Jul 2022 10:01

Wise shares rise 13% on continued growth in revenue and volumes

(Alliance News) - Wise PLC on Tuesday said it has kicked off its new financial year with growth in revenue and volumes, as it aims to lower prices for customers in cross-border transactions.

Read more
19 Jul 2022 09:10

LONDON MARKET OPEN: Apple hits sentiment; Made.com tumbles

(Alliance News) - London shares were on the back foot in early trade on Tuesday, following New York lower after a report that Apple plans to slow hiring due to economic growth fears.

Read more
19 Jul 2022 08:21

CORRECT: LONDON MARKET PRE-OPEN: Informa backs outlook; Made lowers

(Correcting that Made.com first-half sales were 19% lower year-on-year, but up 55% from pre-Covid-19 levels, and not Wise's.)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.